Back to results
US 2022/0008524 A1Published application
Vaccination with microvesicles derived from tumour cells for cancer treatment
OwnerBenjamin Pineda Olvera, Veronica Perez De La Cruzinventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to microvesicles derived from natural tumor cells and tumor cells produced in vitro under a stress stimulus, such as radiation, which can be used in an effective manner as a therapeutic vaccine for cancer. The invention also relates to a therapeutic vaccine formulation containing the microvesicles, processes for the preparation and medical use thereof as a therapeutic vaccine to stimulate the antitumor immune system and treat cancer.
Claims16
Microvesicles derived from in vitro irradiated neoplastic cells, characterized by having a mean size between 200 and 400 nm.
Dependencies are inferred from the claim text.